Epidiolex maker GW Pharma reports record quarterly revenue of $137 million
United Kingdom-based GW Pharmaceuticals posted higher revenue in the quarter ended Sept. 30, largely driven by U.S. sales of its cannabidiol medicine Epidiolex.
United Kingdom-based GW Pharmaceuticals posted higher revenue in the quarter ended Sept. 30, largely driven by U.S. sales of its cannabidiol medicine Epidiolex.
The first finished, registered cannabis medicine became available to patients in Peruvian pharmacies this week, Marijuana Business Daily has learned.
Denmark’s medical cannabis pilot program notched another positive quarter, but the number of unique consumers remains well below the trial’s peak of a year ago.
Australia’s medical cannabis market continues to grow. In September, more than 6,000 patients were approved for medical marijuana treatment through the country’s Special Access Scheme (SAS) Category B pathway.
Spain has several medical cannabis licensed producers, and at least one already exports flower to countries such as Germany.
A new medical cannabis product is available in Peru, another sign the market is moving in the right direction in terms of business opportunities.
Applications for medical cannabis reimbursements with German statutory health insurers (GKV) have hit the 100,000 milestone this year – and 62% were approved, according to data obtained by Marijuana Business Daily.
Insurance reimbursements for cannabis in Germany dropped for the first time – on a quarterly basis – since the current medical program started in early 2017, according to new data for the quarter ended June 30, 2020.
These five countries, which span from Europe to Latin America and Oceania, are worth keeping tabs on for their potential business opportunities down the road.
It turns out there are some healthy, and growing, medical marijuana markets outside the United States and Canada – assuming you can look past the cannabis industry fan fiction.
The Public Health Institute of Chile (ISP) issued a warning recently about CBD products offered for sale online without a required sanitary registration.
Denmark reported small growth in the number of patients accessing its medicinal cannabis pilot program early this year, but the overall market remains very small, according to data recently disclosed by the country’s official e-health portal.